NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
02 April 2025
Name: | GLENEAGLE GOLD LIMITED (GLN) (This company subsequently changed its name to ZELIRA THERAPEUTICS LIMITED. You should refer to that name for Status.) | |||||||||
Date of Listing: | 28 July 2003 | |||||||||
Subsequent Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to ZELIRA THERAPEUTICS LIMITED. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to ZELIRA THERAPEUTICS LIMITED. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now ZELIRA THERAPEUTICS LIMITED. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
FROM | TO | |
ZELIRA THERAPEUTICS LIMITED | 05/12/2019 | |
ZELDA THERAPEUTICS LIMITED | 11/10/2016 | 05/12/2019 |
GLENEAGLE GOLD LIMITED | 11/10/2016 |
Computershare Perth
Level 17, 221 St Georges Terrace, Perth WA 6000
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Zelda Therapeutics Limited | 11/10/2016 |
The company releases its Appendix 4G. | 26/09/2016 |
The company lodges its Annual Report. | 23/09/2016 |
The company has successfully raised the maximum allowed under its prospectus offering. A total of 160,000,000 post-consolidation shares were issued to new investors at 2.5 cents per share raising the full $4,000,000. The offer closed early and over-subscribed reflecting the intense level of interest by investors in supporting our fast-track clinical strategy with our medicinal cannabis medicines. | 20/09/2016 |
The company releases a letter to its shareholders regarding the capital raising for the acquisition of Zelda Therapeutics Pty Ltd. | 04/08/2016 |
The company lodges its Quarterly Activities Report. | 29/07/2016 |
The company lodges its Quarterly Cashflow Report. | 29/07/2016 |
The company releases the results of its meeting. Each resolution was passed on a show of hands. Resolutions 7 and 8 were passed as special resolutions with at least 75% of votes cast by Shareholders present and eligible to vote at the Meeting voting in favour of the resolution. | 25/07/2016 |
The securities of Gleneagle Gold Limited (the "Company") will be suspended from official quotation immediately pending the results of the Company's General Meeting of shareholders. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. | 25/07/2016 |
securities reinstated to quotation | 09/04/2010 |
securities suspended from quotation pending an announcement | 07/04/2010 |
we understand that on or about this date the company consolidated its shares 1 for 11 | 02/10/2008 |
securities reinstated to quotation | 05/05/2008 |
at a meeting of shareholders held on 4 March 2008, the shareholders of the Company approved the various resolutions required to complete the restructuring and recapitalisation of the Company. Following the shareholders' meeting, the Deed of Company Arrangement (DOCA) was terminated, resulting in the extinguishment of all creditor claims, and the management of the Company was returned to the new Directors | 16/04/2008 |
releases half yearly and annual reports | 04/04/2008 |
the Deed of Company Arrangement has been fully effectuated and the Deed Administrators have retired | 11/03/2008 |
we understand that on or about this date the company consolidated its shares 1 for 5 | 06/03/2008 |
shareholders in the general meeting on 4 March resolved to consolidate capital (1 for 5), raise new capital and replace the board with three new directors | 05/03/2008 |
advises of General Meeting to held on March 4 to consider proposals for extinguishing creditors claims and restructuring the company | 30/01/2008 |
the Deed Administrators advise that the Heads of Agreement for the sale of the company's tangible assets is completed and the assets sold | 17/12/2007 |
a conditional deed is entered into to reconstruct and recapitalise the company - a general meeting of shareholders will be held in due course | 04/09/2007 |
the Deed Administrators enter into a Heads of Agreement for the sale of the company's tangible assets | 10/08/2007 |
creditors resolve that the company enter into a deed of company arrangement | 27/07/2007 |
Andrew Birch, Simon Read and Simon Theobald of PPB are appointed administrators - this never augurs well for shareholders and it will be several weeks before the company's position is assessed | 03/05/2007 |
securities suspended from quotation pending an announcement | 30/04/2007 |
name changed to Zelda Therapeutics Limited | 11/10/2016 |
The company releases its Appendix 4G. | 26/09/2016 |
The company lodges its Annual Report. | 23/09/2016 |
The company has successfully raised the maximum allowed under its prospectus offering. A total of 160,000,000 post-consolidation shares were issued to new investors at 2.5 cents per share raising the full $4,000,000. The offer closed early and over-subscribed reflecting the intense level of interest by investors in supporting our fast-track clinical strategy with our medicinal cannabis medicines. | 20/09/2016 |
The company releases a letter to its shareholders regarding the capital raising for the acquisition of Zelda Therapeutics Pty Ltd. | 04/08/2016 |
The company lodges its Quarterly Activities Report. | 29/07/2016 |
The company lodges its Quarterly Cashflow Report. | 29/07/2016 |
The company releases the results of its meeting. Each resolution was passed on a show of hands. Resolutions 7 and 8 were passed as special resolutions with at least 75% of votes cast by Shareholders present and eligible to vote at the Meeting voting in favour of the resolution. | 25/07/2016 |
The securities of Gleneagle Gold Limited (the "Company") will be suspended from official quotation immediately pending the results of the Company's General Meeting of shareholders. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. | 25/07/2016 |
securities reinstated to quotation | 09/04/2010 |
securities suspended from quotation pending an announcement | 07/04/2010 |
we understand that on or about this date the company consolidated its shares 1 for 11 | 02/10/2008 |
securities reinstated to quotation | 05/05/2008 |
at a meeting of shareholders held on 4 March 2008, the shareholders of the Company approved the various resolutions required to complete the restructuring and recapitalisation of the Company. Following the shareholders' meeting, the Deed of Company Arrangement (DOCA) was terminated, resulting in the extinguishment of all creditor claims, and the management of the Company was returned to the new Directors | 16/04/2008 |
releases half yearly and annual reports | 04/04/2008 |
the Deed of Company Arrangement has been fully effectuated and the Deed Administrators have retired | 11/03/2008 |
we understand that on or about this date the company consolidated its shares 1 for 5 | 06/03/2008 |
shareholders in the general meeting on 4 March resolved to consolidate capital (1 for 5), raise new capital and replace the board with three new directors | 05/03/2008 |
advises of General Meeting to held on March 4 to consider proposals for extinguishing creditors claims and restructuring the company | 30/01/2008 |
the Deed Administrators advise that the Heads of Agreement for the sale of the company's tangible assets is completed and the assets sold | 17/12/2007 |
a conditional deed is entered into to reconstruct and recapitalise the company - a general meeting of shareholders will be held in due course | 04/09/2007 |
the Deed Administrators enter into a Heads of Agreement for the sale of the company's tangible assets | 10/08/2007 |
creditors resolve that the company enter into a deed of company arrangement | 27/07/2007 |
Andrew Birch, Simon Read and Simon Theobald of PPB are appointed administrators - this never augurs well for shareholders and it will be several weeks before the company's position is assessed | 03/05/2007 |
securities suspended from quotation pending an announcement | 30/04/2007 |
Your browser may reflect a date of printing in American format.
NAME | TITLE | DATE OF APPT |
---|---|---|
Leon Davies | Non Exec Director | 20/04/2011 |
Ian Love | Director | 23/04/2010 |
Wayne Loxton | Director | 23/04/2010 |
Neville Bassett | Company Secretary |
Date of first appointment, title may have changed.
NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
---|
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.